The history of the erectile dysfunction drug presents a challenging picture for shareholders. While the initial launch generated significant gains, the expiration of its patent opened the floodgates to generic https://jeanggsf111557.dreamyblogs.com/42123353/sildenafil-and-big-pharma-a-risky-opportunity